|
Delayed
OTC Markets
19:27:19 06/07/2026 +04
|
5-day change | 1st Jan Change | ||
| 31.50 USD | -1.25% |
|
-.--% | +5.00% |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-06 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 438M 502M 413M 375M 703M 48.15B 706M 4.95B 1.91B 24.48B 1.88B 1.84B 78.76B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 390M 447M 368M 334M 626M 42.88B 629M 4.41B 1.7B 21.8B 1.68B 1.64B 70.15B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
CBOE
| BOIp | Real-time | |
Börse Stuttgart
| BON | Delayed | |
Boerse Muenchen
| BON | Real-time | |
OTC Markets
| BOIRF | Delayed | |
Deutsche Boerse AG
| BON | Delayed | |
CBOE
| 0DTF | Real-time |
| 1 day | -1.25% | ||
| 3 months | -1.25% | ||
| 6 months | +5.00% | ||
| Current year | +5.00% |
| Current year | 31.5 | 31.9 | |
| 1 year | 30 | 32.28 | |
| 3 years | 24 | 46.22 | |
| 5 years | 24 | 53.5 | |
| 10 years | 24 | 99.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.25% | -.--% | - | - | 502M | ||
| -0.66% | +1.29% | -13.43% | -4.54% | 13.67B | ||
| 0.00% | -2.03% | -33.85% | -56.71% | 4.75B | ||
| -0.68% | -1.86% | -4.96% | -6.97% | 4.34B | ||
| +0.53% | -1.43% | -9.63% | -32.11% | 3.77B | ||
| +0.16% | -1.25% | -1.83% | -3.85% | 3.46B | ||
| +1.38% | -1.43% | -22.34% | -1.00% | 3.39B | ||
| -0.57% | -1.98% | -12.88% | -2.39% | 3.11B | ||
| -0.62% | -0.82% | -23.04% | -18.69% | 2.26B | ||
| +0.52% | -1.97% | -29.31% | -21.61% | 1.63B | ||
| Average | -0.12% | -0.83% | -16.81% | -16.43% | 4.49B | |
| Weighted average by Cap. | -0.19% | -0.59% | -15.46% | -14.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 559M 460M 418M 783M 53.65B 787M 5.51B 2.13B 27.28B 2.1B 2.05B 87.77B | 501M 575M 473M 430M 805M 55.14B 808M 5.67B 2.19B 28.03B 2.16B 2.11B 90.21B |
| Net income | 11.34M 13M 10.7M 9.72M 18.21M 1.25B 18.29M 128M 49.48M 634M 48.83M 47.75M 2.04B | 32.64M 37.43M 30.82M 27.99M 52.44M 3.59B 52.66M 369M 142M 1.83B 141M 138M 5.88B |
| Net Debt | -49.74M -57.04M -46.96M -42.65M -79.9M -5.47B -80.24M -563M -217M -2.78B -214M -210M -8.95B | -47.86M -54.88M -45.19M -41.03M -76.88M -5.27B -77.2M -541M -209M -2.68B -206M -202M -8.61B |
Employees
2,499
Sector
Pharmaceuticals
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
- BOIRF Stock
Select your edition
All financial news and data tailored to specific country editions

















